Sentences with phrase «new glioblastoma patients»

Not exact matches

They are also getting skin cells from glioblastoma patients to make sure the new method works for the people they hope to help, he says.

The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.

University of Calgary researchers including Luchman, Weiss and Dr. Greg Cairncross — director of SACRI, and leader of the Terry Fox Research Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gGlioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblastomaglioblastoma.

NEW YORK — In 30 years as an oncologist, Dr. Howard Fine estimates he has treated some 20,000 patients with glioblastomas, the most deadly form of brain cancer, «and almost all of them are dead.»

A new population - based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer.

Patients with glioblastoma have very few treatment options, and we need to continue our search for new ways to attack this very aggressive cancer.»

While new findings continue to extend the lives of patients with glioblastoma, for the moment, it remains one of the most dreaded diagnoses because despite treatment, GBMs almost always come back, said Bloch.

The ISOMA platform is aiming to be an integral solution for helping advance new treatment options for glioblastoma patients.

ISOMA was launched in 2017 to help advance new treatment paradigms for glioblastoma patients, which are greatly needed and not in existence as of today.